Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

CRISPR Therapeutics AG
Sponsor

CRISPR Therapeutics AG

Baarerstrasse 14, 6300

About the sponsor

Clinical research includes hematologic malignancies and solid malignancies, with attention to long-term outcomes after CAR cellular therapy for cancer.

  • Hematologic malignancy
  • Solid malignancy
  • CAR cellular therapy

These studies focus on malignant disease settings where engineered cell therapies are being evaluated for durable therapeutic activity.

About Specializations

CRISPR Therapeutics AG runs clinical trials in conditions such as Haematological malignancy, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Haematological malignancy

Recruiting

Long-term Safety Study of CRISPR CAR T Cell Therapy for Patients with Blood and Solid Cancers

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Allogeneic Crispr/Cas9-Mediated Genetically Modified Car T Cells Targeting Cd19 Antigen
  • Sponsor:CRISPR Therapeutics AG

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.